checkAd
    PowerTap Hydrogen Capital Aktie
    0,1311
     
    EUR
    +12,92 %
    +0,0150 EUR
    Letzter Kurs 18.08.22 Tradegate
    0,1161
     
    EUR
    26.133 STK
    Geldkurs 18.08.22
    0,1207
     
    EUR
    24.856 STK
    Briefkurs 18.08.22
    ISIN: CA73939X1006 · WKN: A3CSCE · SYM: 2K6B · Kanada

    Neueste Nachrichten

    Powertap Provides Bi-Weekly Status Report
    25.11.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Provides Bi-Weekly Status Report
    11.11.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Provides Bi-Weekly Status Report
    28.10.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Provides Bi-Weekly Status Report
    13.10.23 · globenewswire · PowerTap Hydrogen Capital
    Powertap Announces Late Filing of Annual Financial Statements and Management Cease Trade Order
    30.09.23 · globenewswire · PowerTap Hydrogen Capital
    Major Global Truck OEM to Expand Fueling Network with PowerTap and Its Unique On-Site Hydrogen Production and Dispensing Unit in a Strategic Partnership
    22.09.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Hydrogen Fueling Corp. and Coleman Industrial Gases, LLC Sign a Strategic Partnership-based "Letter of Intent" to Negotiate and Execute a CO2 and Hydrogen Purchase Agreement
    19.09.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Announces Amended and Restated Q3 2023 Management Discussion & Analysis
    25.07.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Hydrogen Fueling Corp. and Cleantech Power Corp. Enter Into Letter of Intent for Collaborative Energy Project Development
    01.07.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Announces Financing
    28.06.23 · globenewswire · PowerTap Hydrogen Capital
    PowerTap Announces Results of Annual General Meeting and Resignation of Former Auditor
    10.06.23 · globenewswire · PowerTap Hydrogen Capital
    Powertap Announces Share Consolidation (Reverse Stock Split)
    06.06.23 · globenewswire · PowerTap Hydrogen Capital